Novartis to Buy AveXis in $8.7 Billion US Gene-Therapy Deal – Bloomberg
|
Novartis to Buy AveXis in $8.7 Billion US Gene–Therapy Deal
Bloomberg Novartis AG agreed to acquire AveXis Inc. for $8.7 billion to expand its position in gene therapy. Switzerland-based Novartis is buying the Bannockburn, Illinois, company for $218 a share, representing a premium of 88 percent to AveXis's closing price … |
